Quercetin and Allergic Rhinitis: What Does the Clinical Trial Show?

Quercetin is a flavonoid found in many food plants — onions, apples, capers, broccoli, red wine, and numerous herbs. For decades it has been studied in the lab for its antioxidant and anti-inflammatory properties, and in vitro studies have shown it can inhibit histamine release from mast cells and reduce production of some pro-inflammatory cytokines involved in the allergic response.

These mechanistic findings have earned quercetin a place in popular supplement lore as a "natural antihistamine" — a label repeated far more often in supplement shops and online forums than the actual body of solid human clinical trials would justify. Much of the enthusiasm around quercetin rests on cell or animal experiments rather than well-designed clinical trials in patients with real allergic rhinitis symptoms.

Allergic rhinitis (commonly known as hay fever or pollinosis) affects a significant share of the population and presents with sneezing, itchy and runny nose, nasal congestion, and itchy eyes — symptoms that can meaningfully worsen sleep quality and daily functioning during pollen season. In this article we look at what one of the few randomized clinical trials actually testing a quercetin supplement in people with these symptoms found.

It's worth noting that the effect wasn't limited to a single symptom but spanned several different dimensions of allergy-related quality of life at once — eye itching, sneezing, nasal discharge, and sleep quality. That points to a broader effect, consistent with the antihistamine and anti-inflammatory mechanism described in laboratory studies, rather than an improvement confined to one isolated measure.

The allergic reaction in the nasal mucosa begins with degranulation of mast cells after contact with an allergen — these cells release histamine and other inflammatory mediators, leading to the classic symptoms: swelling, itching, sneezing, and excess mucus production. In vitro studies show that quercetin can stabilize the mast cell membrane and reduce histamine release, and can also inhibit the activity of certain enzymes involved in the inflammatory pathway (such as lipoxygenase) and lower production of pro-inflammatory cytokines.

This mechanism is still derived mainly from cell and animal studies — its translation into real clinical effects in humans isn't a given, since quercetin's absorption from the digestive tract is limited and depends on its chemical form (aglycone vs. glycosides), other components of the meal it's taken with, and individual metabolism. The study discussed above is one of the few that actually tested whether this mechanism translates into a noticeable improvement in symptoms in people, rather than just biochemical markers in a test tube.

This distinction has practical significance: someone with severe allergic rhinitis symptoms who stops a proven antihistamine in favor of quercetin alone, expecting a comparable effect, may experience much worse symptom control than with their previous treatment. Based on current data, quercetin looks more like a potential add-on than a substitute for pharmacological treatment.

In the study discussed, a supplement containing 200 mg of quercetin daily was well tolerated, and the reported adverse effects were few and minor. Quercetin at doses used in supplementation is generally considered well tolerated in the short and medium term, though safety data for very long-term, multi-year use at high doses are limited.

Quercetin is one of the few "allergy supplements" with real, though still singular, clinical confirmation in humans rather than laboratory studies alone. That's reason enough to take the topic seriously, but not enough to declare quercetin a proven treatment for allergic rhinitis.